THEMISMEDPharmaceuticals
Themis Medicare Ltd — PE Ratio & Valuation Analysis
₹66.07
-9.59%
Current P/EN/AxPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E34.6x100.0% below avg
✅
100.0% Discount to Industry
THEMISMED P/E N/Ax vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹3.24 | ₹101 | 31x |
| 2024 | ₹4.72 | ₹264 | 55.8x |
| 2023 | ₹6.17 | ₹214 | 34.6x |
| 2022 | ₹7.91 | ₹135 | 17.1x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Themis Medicare Ltd Valuation
Themis Medicare Ltd (THEMISMED) currently trades at N/Ax earnings. The Pharmaceuticals sector average PE is 31.77x. Historically, THEMISMED has traded at an average PE of 34.6x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
7.65%
Dividend Yield
0.48%
More on Themis Medicare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.